FLGT - Fulgent Genetics, Inc. Stock Analysis | Stock Taper
Logo

About Fulgent Genetics, Inc.

https://www.fulgentgenetics.com

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.

Ming Hsieh

CEO

Ming Hsieh

Compensation Summary
(Year 2024)

Salary $1,000,000
Stock Awards $4,000,000
Incentive Plan Pay $1,128,000
Total Compensation $6,128,000
Industry Medical - Diagnostics & Research
Sector Healthcare
Went public September 29, 2016
Method of going public IPO
Full time employees 1,313

ETFs Holding This Stock

Ratings Snapshot

Rating : B

Discounted Cash Flow 5
Return On Equity 1
Return On Assets 1
Debt To Equity 4
Price To Earnings 1
Price To Book 4
Overall Score 3

Most Recent Analyst Grades

Grade Summary

Buy 1
Outperform 1
Neutral 1

Showing Top 3 of 3

Price Target

Target High $36
Target Low $21
Target Median $30
Target Consensus $29

Institutional Ownership

Summary

% Of Shares Owned 77.18%
Total Number Of Holders 204

Showing Top 3 of 204